Biomedical engineers from several universities developed a microfluidics, or lab-on-a-chip, device that uses sound waves to quickly isolate tiny packets of cell materials for detecting diseases. . . . → Read More: Microfluidics, Sound Waves Combined for Liquid Biopsies
|
|||||
|
|
A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines. . . . → Read More: Avian Flu Vaccine with Longer Protection in Development Experimental treatments using patients’ own stem cells were shown in a pilot test to heal painful chronic wounds on their legs and feet. . . . → Read More: Stem Cells Shown to Heal Chronic Leg Wounds A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital. . . . → Read More: 3-D Organ Printing Company Gains Seed Funds The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals A consortium of engineering labs is designing a system translating commands in the brain to prosthetic devices that help people walk with spinal cord injury. . . . → Read More: Brain-Computer Link in Development for Spinal Injury A university spin-off enterprise developing robotics to make cochlear implants for hearing loss safer and more effective is receiving a Small Business Innovation Research, or SBIR, grant to advance its technology. . . . → Read More: Cochlear Implant Robotics Start-Up Gains NIH Funds Engineering researchers designed a tiny chip device that identifies precise locations inside the body, a key feature for ingestible medical devices. . . . → Read More: Microchips Designed for Tracking Bodily Functions A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
